COVID-19 vaccine trials should seek worthwhile efficacy

被引：87
|
作者：
Krause, Philip [1 ]
Fleming, Thomas R. [2 ]
Longini, Ira [3 ]
Henao-Restrepo, Ana Maria [4 ]
Peto, Richard [5 ]
机构：
[1] US FDA, Ctr Biol Evaluat & Res, Washington, DC 20204 USA
[2] Univ Washington, Fred Hutchinson Canc Ctr, Seattle, WA 98195 USA
[3] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Biostat, Coll Med, Gainesville, FL USA
[4] World Hlth Org, Hlth Emergencies Programme, CH-1211 Geneva 27, Switzerland
[5] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England
来源：
LANCET | 2020年 / 396卷 / 10253期
关键词：
D O I：
10.1016/S0140-6736(20)31821-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：741 / 743
页数：4
相关论文
共 50 条
  • [1] NEWS ANALYSIS Covid-19: Should vaccine trials be unblinded?
    Lenzer, Jeanne
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 371 : m4956
  • [2] Review of COVID-19 Variants and COVID-19 Vaccine Efficacy: What the Clinician Should Know?
    Vasireddy, Deepa
    Vanaparthy, Rachana
    Mohan, Gisha
    Malayala, Srikrishna Varun
    Atluri, Paavani
    JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2021, 13 (06): : 317 - 325
  • [3] Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials
    Mehrotra, Devan, V
    Janes, Holly E.
    Fleming, Thomas R.
    Annunziato, Paula W.
    Neuzil, Kathleen M.
    Carpp, Lindsay N.
    Benkeser, David
    Brown, Elizabeth R.
    Carone, Marco
    Cho, Iksung
    Donnell, Deborah
    Fay, Michael P.
    Fong, Youyi
    Han, Shu
    Hirsch, Ian
    Huang, Ying
    Huang, Yunda
    Hyrien, Ollivier
    Juraska, Michal
    Luedtke, Alex
    Nason, Martha
    Vandebosch, An
    Zhou, Honghong
    Cohen, Myron S.
    Corey, Lawrence
    Hartzel, Jonathan
    Follmann, Dean
    Gilbert, Peter B.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (02) : 221 - +
  • [4] Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials
    Turley, Christine B.
    Tables, LaKesha
    Fuller, Trevon
    Sanders, Lisa J.
    Scott, Hyman
    Moodley, Amaran
    Davis, Amanda Woodward
    Leav, Brett
    Miller, Jacqueline
    Schoemaker, Kathryn
    Vandebosch, An
    Sadoff, Jerald
    Woo, Wayne
    Cho, Iksung
    Dunkle, Lisa M.
    Li, Sijia
    van der Laan, Lars
    Gilbert, Peter B.
    Follmann, Dean
    Jaynes, Holly
    Kublin, James G.
    Baden, Lindsey R.
    Goepfert, Paul
    Kotloff, Karen
    Gay, Cynthia L.
    Falsey, Ann R.
    El Sahly, Hana M.
    Sobieszczyk, Magdalena E.
    Huang, Yunda
    Neuzil, Kathleen M.
    Corey, Lawrence
    Grinsztejn, Beatriz
    Gray, Glenda
    Rouphael, Nadine
    Luedtke, Alex
    VACCINE, 2023, 41 (33) : 4899 - 4906
  • [5] Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials
    Dean, Natalie E.
    Piontti, Ana Pastore Y.
    Madewell, Zachary J.
    Cummings, Derek A. T.
    Hitchings, Matthew D. T.
    Joshi, Keya
    Kahn, Rebecca
    Vespignani, Alessandro
    Halloran, M. Elizabeth
    Longini, Ira M., Jr.
    VACCINE, 2020, 38 (46) : 7213 - 7216
  • [6] The design and analysis of vaccine trials for COVID-19 for the purpose of estimating efficacy
    Senn, Stephen
    PHARMACEUTICAL STATISTICS, 2022, 21 (04) : 790 - 807
  • [7] The Case for Why Africa Should Host COVID-19 Candidate Vaccine Trials
    Singh, Jerome Amir
    JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (03): : 351 - 355
  • [8] COVID-19 vaccine trials in Africa
    Makoni, Munyaradzi
    LANCET RESPIRATORY MEDICINE, 2020, 8 (11): : E79 - E80
  • [9] VIEWPOINT: COVID-19 Understanding COVID-19 vaccine efficacy
    Lipsitch, Marc
    Dean, Natalie E.
    SCIENCE, 2020, 370 (6518) : 763 - 765
  • [10] Comment on "COVID-19 vaccine efficacy "
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (03) : 307 - 307
12345